Antibodies to CD36 (GPIV) inhibit platelet adhesion to subendothelial surfaces under flow conditions

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 7, 1996, Pages 883-888

  Diaz Ricart, Maribel ^a   Tandon, Narendra N ^b   Gómez Ortiz, Goretti ^a   Carretero, Marta ^a   Escolar, Ginés ^a   Ordinas, Antonio ^a   Jamieson, G A ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b AMERICAN RED CROSS   (United States)

Author keywords

glycoprotein IV; perfusion; platelet adhesion; subendothelium

Indexed keywords

CD36 ANTIGEN; COLLAGEN TYPE 1; GLYCOPROTEIN;

ARTICLE; CORONARY ARTERY BLOOD FLOW; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MULTIGENE FAMILY; PERFUSION; PRIORITY JOURNAL; SUBENDOTHELIUM; THROMBOCYTE ADHESION;

EID: 0030018581     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.7.883     Document Type: Article

References (28)

1. Hawiger J. Formation and regulation of platelet and fibrin hemostatic plug. Hum Pathol. 1987;18:111-122.
2. Nieuwenhuis HK, Akkerman JWN, Houdijk WPM, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature. 1985;318:470-472.
3. Nieuwenhuis HK, Sakariassen KS, Houdijk WPM, Nievelstein PFEM, Sixma JJ. Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood. 1986;68:692-695.
4. Arai M, Yamamoto N, Moroi M, Akamatsu N, Fukutake K, Tanoue K. Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency. Br J Haematol. 1995;89:124-130.
5. Moroi M, Jung SM, Okuma M, Shinmyozu K. A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest. 1989;84:1440-1445.
6. Tandon NN, Kralisz U, Jamieson GA. Identification of GPIV (CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem. 1989;264:7576-7583.
7. Tandon NN, Ockenhouse CF, Greco NJ, Jamieson GA. Adhesive functions of platelets lacking GPIV (CD36). Blood. 1991;78:2809-2813.
8. Diaz-Ricart M, Tandon NN, Carretero M, Ordinas A, Bastida E, Jamieson GA. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood. Blood. 1993;82:491-496.
9. Beer JH, Rabaglio M, Berchtold P, von Felten A, Clemetson KJ, Tsakiris DA, Kehrel B, Bradenberger S. Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction. Blood. 1993;82:820-829.
10. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA. Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine. Blood. 1992;80:1105-1115.
11. Tandon NN, Diaz-Ricart M, Lotfalian B, Ockenhouse CF, Jamieson GA. Different domains of CD36 mediate collagen adhesion and malarial cytoadherence. Thromb Haemost. 1995;73:1742. Abstract.
12. Mercier N, Catimel B, Reck MP, Pellecchia D. McGregor JL. Identification of a functional site on CD36 involved in the interaction between platelets and collagen. Platelets. 1995;6:139-145.
13. Asch AS, Liu I, Briccetti FM, Barnwell JW, Kwakye-Berko F, Dokun A, Goldberger J, Pernambuco M. Analysis of CD36 binding domains: ligand specificity controlled by dephosphorylation of an ectodomain. Science. 1993;262:1436-1440.
14. a- platelets lack detectable GPIV (CD36). Blood. 1990;76:1698-1703.
15. Jaffe E, Minick C, Adelman B, Becker C, Nachman R. Synthesis of basement membrane collagen by cultured human endothelial cells. J Exp Med. 1976;144:209-225.
16. Aznar-Salatti J, Bastida E, Haas TA, Escolar G, Ordinas A, de Groot PG, Buchanan MR. Platelet adhesion to exposed endothelial cell extracellular matrices is influenced by the method of preparation. Arterioscler Thromb. 1991;11:436-442.
17. Matsuno K, Diaz-Ricart M, Montgomery RR, Aster RH, Jamieson GA, Tandon NN. Inhibition of platelet adhesion to collagen by monoclonal anti-CD36 antibodies. Br J Haematol. 1996;92:960-967.
18. Baumgartner HR. The role of blood flow in platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res. 1973;5:167-176.
19. Sakariassen KS, Aarts PAMM, de Groot PGJ, Houdijk WMP, Sixma JJ. A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med. 1983;102:522-535.
20. Baumgartner HR. Platelet interaction with collagen fibrils in flowing blood: reaction of human platelets with α-chymotrypsin digested sub-endothelium. Thromb Haemost. 1977;37:1-15.
21. Escolar G, Garrido M, Aznar-Salatti J, Ordinas A, Bastida E. Comparison between human umbilical artery and rabbit abdominal aorta as substrata for platelet adhesion and platelet thrombus formation under flow conditions. Blood Vessels. 1991;28:520-531.
22. Agbanyo FR, Sixma JJ, de Groot PG, Languino LR, Plow EF. Thrombospondin-platelet interactions: role of divalent cations, wall shear rate and platelet membrane glycoproteins. J Clin Invest. 1993;92:288-296.
23. Li W-X, Howard RJ, Leung LL. Identification of SVTCG in thrombospondin as the conformation-dependent, high affinity binding site for its receptor, CD36. J Biol Chem. 1993;268:16179-16184.
24. Leung LLK, Li WX, McGregor JL, Albrecht G, Howard RJ. CD36 peptides enhance or inhibit CD36-thrombospondin binding: a two-step process of ligand-receptor interaction. J Biol Chem. 1992;267:18244-18250.
25. McKeown L. Vail M, Williams S, Kramer W, Hansmann K, Gralnick H. Platelet adhesion to collagen in individuals lacking glycoprotein IV. Blood. 1994;83:2866-2871.
26. Saelman EUM, Kehrel B, Hese KM, de Groot PG, Sixma JJ, Nieuwenhuis HK. Platelet adhesion to collagen and endothelial cell matrix under flow conditions is not dependent on platelet glycoprotein IV. Blood. 1994;83:3240-3244.
27. 2+-dependent and bivalent-cation-independent adhesion. Biochem J. 1990;268:481-486.
28. Lozano M, Bos A, de Groot PG, van Willigen G, Meuleman DG, Ordinas A, Sixma JJ. Suitability of low-molecular-weight heparin(oid)s and a pentasaccharide for an in vitro human thrombosis model. Arterioscler Thromb. 1994;14:1215-1222.